As of December 2024, Oramed Pharmaceuticals has a market cap of $100.44M. This makes Oramed Pharmaceuticals the world's 20077th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $129.12M | 38.56% |
2023 | $93.18M | -80.80% |
2022 | $485.28M | -15.76% |
2021 | $576.04M | 236.79% |
2020 | $171.04M | -17.67% |
2019 | $207.75M | 71.67% |
2018 | $121.02M | -66.67% |
2017 | $363.05M | 47.06% |
2016 | $246.87M | -28.42% |
2015 | $344.90M | 87.50% |
2014 | $183.95M | -70.45% |
2013 | $622.43M | 289.65% |
2012 | $159.74M | 17.86% |
2011 | $135.54M | -6.67% |
2010 | $145.22M | -33.33% |
2009 | $217.83M | 15.38% |
2008 | $188.79M | 50.00% |
2007 | $125.86M | - |